Spots Global Cancer Trial Database for pphm 1202
Every month we try and update this database with for pphm 1202 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer | NCT01999673 | Non-Small-Cell ... Non-Small-Cell ... Non-Small-Cell ... Carcinoma, Non-... Non-Small Cell ... Non-Small-Cell ... Nonsmall Cell L... | bavituximab Docetaxel Placebo (for ba... | 18 Years - | Peregrine Pharmaceuticals |